Target-Market Assessment
Compare feasibility, requirements, timelines and entry complexity before committing resources.
Market priorityFeasibility
International regulatory strategyBuild one foundation.
Build one foundation.
Navigate many markets.
Ziva DRA turns regulatory complexity into a sequenced international expansion program—connecting evidence, documentation, quality readiness and country-specific execution.
COREReusable dossierLOCALMarket adaptationSCALEPortfolio program
MARKET ACCESS ATLASLIVE STRATEGY VIEW
COREDOSSIER
AMERICASPathway 01EUROPEPathway 02ASIAPathway 03MENAPathway 04 Common evidence Local requirement01—04 / TARGET PATHWAYS
THE OPERATING PRINCIPLEStandardize the core.
Standardize the core.
Localize the pathway.
International expansion works when reusable documentation is separated from jurisdiction-specific requirements early. That distinction reduces duplication while preserving the work each market genuinely requires.
1PRODUCTNMARKETS
REGULATORY ARCHITECTURE
Design a strategy that can travel.
Build a common regulatory foundation, expose the gaps, and translate it into controlled market-specific workstreams.
Regulatory Gap Analysis
Determine which approvals and documents can travel—and what each target market still needs.
Reusable assetsEvidence gaps
Dossier & Quality Readiness
Connect technical documentation, manufacturing controls and quality-system evidence.
Core dossierGMP readiness
Country-Specific Pathways
Adapt the foundation to local classification, labeling, evidence and representation rules.
Local filingLifecycle
GLOBAL MARKET ACCESS SERVICES
Infrastructure for international expansion.
Choose one focused workstream or orchestrate several under a coordinated multi-market program.
01TECHNICAL DOCUMENTATION
Dossier Preparation
Create a coherent submission-ready technical package designed for country adaptation.
Explore service ↗02MANUFACTURING COMPLIANCEGMP Consulting
Align manufacturing systems and quality evidence with market-access expectations.
Explore service ↗03REGULATORY PLANNINGGlobal Regulatory Strategy
Develop the market sequence, dependencies and regulatory roadmap across jurisdictions.
Discuss strategy ↗04READINESS ASSESSMENTRegulatory Gap Assessment
Review approvals, evidence, quality records and technical files against target-market needs.
Request assessment ↗05MARKET PLANNINGMarket Entry Strategy
Combine regulatory feasibility with commercial priorities to establish a practical sequence.
Explore intelligence ↗06INTEGRATED PROGRAMMulti-Country Program
Coordinate shared documentation, local adaptations and regulatory workstreams at scale.
Start program ↗EXPANSION SEQUENCE
Move market by market—without rebuilding from zero.
A controlled sequence creates learning, strengthens the reusable core and makes every subsequent pathway more predictable.
Build your market sequence →PRIORITIZE
MARKETSelect commercial markets
Rank opportunity against regulatory effort.
ASSESS
READINESSExpose regulatory gaps
Map pathway, evidence and quality needs.
PREPARE
FOUNDATIONStrengthen the core file
Build documentation designed for reuse.
ADAPT
COUNTRYLocalize each pathway
Address country-specific requirements.
EXPAND
SCALEExecute and maintain
Coordinate filings and lifecycle activity.
PORTFOLIO VIEW
Regulated sectors. Different expansion logic.
The route atlas changes with the product category, evidence burden, quality framework and intended markets.
MD
MEDICAL DEVICESDevice portfolios
Technical documentation, classification, evidence and quality-system pathways.
SAFETY / PERFORMANCEIVD
DIAGNOSTICSIVD technologies
Performance evidence, risk classification and diagnostic-market access planning.
PERFORMANCE / RISKRX
PHARMACEUTICALSMedicine portfolios
Dossier architecture, GMP readiness and pharmaceutical market-entry programs.
DOSSIER / QUALITYCH
CONSUMER HEALTHCosmetics & personal care
Classification, labeling and compliance planning across consumer-health markets.
CLAIMS / LABELINGFLEXIBLE ENGAGEMENT MODEL
One new market—or an entire international program.
Market-Entry Sprint
For a single new jurisdiction or one defined regulatory challenge.
- Target-market assessment
- Documentation review
- Regulatory gap analysis
- Dossier preparation
- Market-entry roadmap
Global Expansion Program
For several jurisdictions, products or connected regulatory workstreams.
- Multi-market prioritization
- Core dossier strategy
- GMP and quality readiness
- Country-specific adaptations
- Portfolio coordination
CONNECTED EXECUTION
Expansion draws on more than one discipline.
Connect the international roadmap with product registration, clinical evidence and local operating compliance.
QUESTIONS / ANSWERSGlobal access,
Global access,
without the fog.
Start with the product, current approvals, available documentation and intended markets.
Can Ziva DRA help select the first international market?+
Yes. Regulatory complexity, documentation readiness and market priorities can be assessed before an expansion sequence is defined.
Can one dossier be used in multiple countries?+
Parts of a core package may be reusable, while local formatting, evidence, administrative and product requirements may still apply.
Can you review existing approvals and documentation?+
Yes. Existing registrations, technical files, quality information and evidence can be mapped against additional target markets.
Can GMP and dossier work be handled together?+
Yes. Manufacturing readiness and dossier development can be coordinated inside one regulatory program.
Can several countries be managed under one project?+
Yes. A shared regulatory foundation can support separate country-specific workstreams under one coordinated program.
READY TO CROSS THE NEXT BORDER?
Start a global project ↗Turn your product portfolio into a structured global roadmap.
Share the target markets, existing approvals and documentation. We’ll map the gaps and sequence the work.